Stay updated on MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial

Sign up to get notified when there's something new on the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A sitewide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and points visitors to related updates and FAQs.
    Difference
    0.7%
    Check dated 2026-10-24T22:30:05.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer’s displayed ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T22:33:16.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T22:23:32.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    - The version history now includes a new Revision: v3.7.0 entry, and the previous Revision: v3.6.6 entry is removed from the study record history.
    Difference
    0.1%
    Check dated 2026-09-19T21:50:16.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.6' was added to the study record history. The previous 'Revision: v3.6.5' entry was removed, reflecting an update to the record's versioning.
    Difference
    0.1%
    Check dated 2026-08-29T19:42:33.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    A new revision entry labeled 'Revision: v3.6.5' appears in the history, replacing the previous 'Revision: v3.6.4'.
    Difference
    0.1%
    Check dated 2026-08-08T19:02:13.000Z thumbnail image

Stay in the know with updates to MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page.